Dermagnostix kündigt Übernahme und Fortführung der Fluoreszenzdetektor Technologie von Dialunox zum 01.07.2025 an

Die Dermagnostix GmbH aus Freiburg, spezialisiert auf die Entwicklung molekulardiagnostischer Tests für dermatologische Fragestellungen, erweitert ihr Leistungsportfolio durch die Übernahme und Fortführung der Fluoreszenzdetektor Technologie der Dialunox GmbH i.L. aus Stockach zum 01.07.2025.

read more
Dermagnostix kündigt Übernahme und Fortführung der Fluoreszenzdetektor Technologie von Dialunox zum 01.07.2025 an

Dermagnostix announces acquisition and continuation of the fluorescence detector technology of Dialunox as of July 1st 2025

The Dermagnostix GmbH from Freiburg, specialized on the development of molecular diagnostic tests for dermatology, expands its portfolio by the acquisition and continuation of the fluorescence detector technology of Dialunox GmbH i.L. (Stockach) as of July 1st 2025.

read more
Dermagnostix announces acquisition and continuation of the fluorescence detector technology of Dialunox as of July 1st 2025

State Parliament President Muhterem Aras and Member of Parliament Nadyne Saint-Cast Visit Dermagnostix in Freiburg

Muhterem Aras and Nadyne Saint-Cast recently visited Dermagnostix. Together with Dermagnostix’ managing directors Natalie Garzorz-Stark and Ludwig Gutzweiler they discussed the challenges and opportunities for healthcare start-ups, highlighting the role of political support for private investments.

read more
State Parliament President Muhterem Aras and Member of Parliament Nadyne Saint-Cast Visit Dermagnostix in Freiburg